Author: EvolveMKD

Posted Date:

March 25, 2026

Lynch Regenerative Medicine Expands Pure PDGF Portfolio with GEM 21S® Distribution Rights

EvolveMKD

March 25, 2026
Turbine Secures $25M Series B Led by Interactive Venture Partners with participation from Beiersdorf Venture Capital, Announces First Immunology Partnership with Top 10 Pharma Company

EvolveMKD

February 24, 2026
Lynch Regenerative Medicine Bolsters Executive Leadership with Appointment of General Counsel Madison Dini and Chief Marketing Officer Chad Lindemann

EvolveMKD

February 18, 2026